COGT compared with DNTH: revenue, margins and what each company keeps, and the suppliers and customers both name

COGTCogent Biosciences, Inc.

Mkt capRevenueRevenue

DNTHDianthus Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

COGTCogent Biosciences, Inc.

DNTHDianthus Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

COGT

0 of 4at or beyond implied

Reportimpliedrealized× implied

Aug 10 '26±9.6%▼−2.03%×0.21

May 5 '26±9.5%▲+0.68%×0.07

Feb 17 '26±7.5%▲+2.98%×0.40

Nov 3 '25±37.0%▼−4.91%×0.13

DNTH

1 of 4at or beyond implied

Reportimpliedrealized× implied

Nov 5 '26±8.9%▼−3.26%×0.37

Aug 5 '26±9.7%▲+1.90%×0.20

= impliedCOGT realized, solidDNTH realized, hatchedOne scale, both sides: full bar = 37%× = |realized| ÷ impliedSource: market data

May 6 '26

±7.6%

▲+0.20%

×0.03

Mar 9 '26±11.9%▲+21.52%×1.81

COGTCogent Biosciences, Inc.

29.54· pre 30.29· delayed

Mkt cap$5.1BRevenue—Revenue—

DNTHDianthus Therapeutics, Inc.

83.12· pre 82.17· delayed

Pre-marketNov 6 '26delayed

Mkt cap$4.8BRevenue$1MQ3 FY26Revenue$6MFY24

Compare

Pre-marketNov 6 '26delayed

COGTCogent Biosciences, Inc.

DNTHDianthus Therapeutics, Inc.

29.54pre 30.29delayed

Price

83.12pre 82.17delayed

$5.1B

Mkt cap

$4.8B

—

Revenue

$1MQ3 FY26

—

Revenue

$6MFY24

COGT29.54vsDNTH83.12Pre-marketNov 6 '26delayed